[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650117":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":26,"locations":34,"responsibleParty":50,"collaborators":52,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":10,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Tomsk National Research Medical Center of the Russian Academy of Sciences","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients after cardiovascular surgery",null,"Patients of 18 years and older, after cardiac and\u002For vascular surgical intervention during the current hospitalization, who signed informed consent for the use of their anonymized data for scientific purposes",[13],"Other: Not applicable- observational study",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"Not applicable- observational study",[9],[19,23],{"name":20,"affiliation":21,"role":22},"Alla A. Boshchenko, MD, PhD, DSc","Cardiology Research Institute of Tomsk NRMC","STUDY_DIRECTOR",{"name":24,"affiliation":21,"role":25},"Tatiana P. Kalashnikova, MD, PhD","PRINCIPAL_INVESTIGATOR",[27,31],{"name":20,"role":28,"phone":29,"phoneExt":10,"email":30},"CONTACT","+ 7 (3822)-909055","bosh@cardio-tomsk.ru",{"name":24,"role":28,"phone":32,"phoneExt":10,"email":33},"+7 913 814 1664","kalashnikova-t@mail.ru",[35],{"facility":36,"status":37,"city":38,"state":10,"zip":10,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia","RECRUITING","Tomsk","Russia","RU",{"type":42,"coordinates":43},"Point",[44,45],84.98216,56.50049,{"lat":45,"lon":44},[48],{"name":24,"role":28,"phone":49,"phoneExt":10,"email":33},"+7 913 8141664",{"type":51,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[53,56],{"name":54,"class":55},"National Research Tomsk State University","UNKNOWN",{"name":57,"class":6},"Research Institute for Complex Problems of Cardiovascular Diseases, Russia","100650117","pneumonia-after-cardiovascular-surgery-with-an-artificial-intelligence-100650117",false,"NCT07745491","Pneumonia After Cardiovascular Surgery With Artificial Intelligence","Hospital-acquired Pneumonia After Cardiovascular Surgery (CS): the Prediction and Assessment of Long-term Cardiovascular and Pulmonary Outcomes With Artificial Intelligence (AI) - (PNEUMONIA-CS-AI)","Inclusion Criteria:\n\n* Age ≥ 18 years;\n* Cardiac and\u002For vascular surgical intervention during the current hospitalization;\n* Signed informed consent from the patient for the use of their anonymized data for scientific purposes.\n\nExclusion Criteria:\n\n* Use of systemic antibacterial drugs within 30 days prior to the surgical intervention;\n* Prescription of systemic antibacterial drugs during the hospitalization period for any indication other than hospital-acquired pneumonia;\n* HIV infection.","ALL","18 Years",{"count":68,"type":69},700,"ESTIMATED","OBSERVATIONAL","This multicenter, prospective, observational study aims to address two primary objectives.\n\nThe first objective is to demonstrate that hospital-acquired pneumonia (nosocomial pneumonia) following cardiac surgery can be predicted using artificial intelligence (AI), and to develop a personalized risk calculator for its development.\n\nThe second objective is to demonstrate that hospital-acquired pneumonia can serve as a risk factor for a 1-year composite cardiovascular and pulmonary outcome after cardiac surgery, and to develop a personalized risk calculator for this composite outcome.\n\nThe composite outcome will include the occurrence of any of the following events:\n\n* Respiratory death\n* Hospitalization for respiratory diseases\n* Development of oxygen dependence\n* New-onset asthma, COPD, or interstitial lung disease\n* Initiation or intensification of bronchodilator or corticosteroid therapy\n* Cardiovascular death\n* Acute myocardial infarction\n* Unstable angina\n* Myocardial revascularization\n* Acute ischemic stroke\n* Transient ischemic attack\n* Acute heart failure\n* Hospitalization for decompensated heart failure\n* New-onset atrial fibrillation or ventricular tachycardia\n* Initiation or intensification of antiarrhythmic therapy Both objectives will be addressed using artificial intelligence technologies applied during the data analysis phase.\n\nThis is a non-interventional study. Patient evaluation and treatment are conducted in strict accordance with approved standards of medical care for the respective conditions. No experimental or unregistered (not approved for use in the Russian Federation) medical or diagnostic procedures will be performed during this study.",[73],"Hospital Acquired Pneumonia",[75,76,77],"Hospital acquired pneumonia","Risk factors","Composite Cardiovascular and Pulmonary outcomes","2026-08-06",{"date":80,"type":81},"2026-08-11","ACTUAL",{"date":83,"type":81},"2026-07-29",{"date":85,"type":69},"2028-09-30",{"name":5,"class":6},1]